JP Morgan raises Chubb target to $374, joins peers
JP Morgan analyst Pablo Singzon maintained a Neutral rating on Chubb and raised the price target to $374 from $340. This move aligns with similar revisions by other firms, including Citizens, Wells Fargo, and UBS, which have also increased their price targets for the insurance company.
*this image is generated using AI for illustrative purposes only.
JP Morgan analyst Pablo Singzon has maintained a Neutral rating on Chubb while raising the price target from $340 to $374, joining other firms in revising valuations for the insurance company listed on the NYSE under the ticker symbol CB. This adjustment reflects updated financial models or market conditions, with the Neutral rating suggesting the stock is expected to perform in line with the broader market or sector average.
Rating and Price Target Details
JP Morgan's revision follows similar actions by other major financial institutions. Citizens analyst Matthew J. Carletti maintained a Market Outperform rating on Chubb while raising the price target from $365 to $400. Wells Fargo analyst Elyse Greenspan maintained an Equal-Weight rating on Chubb while raising the price target from $333 to $358. Cantor Fitzgerald analyst Ryan Tunis maintained a Neutral rating on Chubb while raising the price target from $318 to $337. Mizuho analyst Yaron Kinar maintained a Neutral rating on Chubb while increasing the price target from $335 to $352. Morgan Stanley analyst Bob Huang maintained an Equal-Weight rating on Chubb while increasing the price target. Keefe, Bruyette & Woods analyst Meyer Shields maintained an Outperform rating, signaling expectations for the stock to beat the market. UBS analyst Brian Meredith maintained a Neutral rating while raising the price target.
| Firm | Analyst | Rating | Previous Price Target | New Price Target |
|---|---|---|---|---|
| JP Morgan | Pablo Singzon | Neutral | $340 | $374 |
| Citizens | Matthew J. Carletti | Market Outperform | $365 | $400 |
| Wells Fargo | Elyse Greenspan | Equal-Weight | $333 | $358 |
| Cantor Fitzgerald | Ryan Tunis | Neutral | $318 | $337 |
| Mizuho | Yaron Kinar | Neutral | $335 | $352 |
| Morgan Stanley | Bob Huang | Equal-Weight | $330 | $340 |
| Keefe, Bruyette & Woods | Meyer Shields | Outperform | $374 | $389 |
| UBS | Brian Meredith | Neutral | $340 | $369 |
The collective price target increases across these firms suggest higher expectations for Chubb's performance. Chubb continues to be monitored by analysts for its performance in the insurance sector.
What specific factors are driving the widespread upward revision of Chubb's price targets across multiple firms?
How might Chubb's performance compare to the broader insurance sector given the mixed ratings?
What potential market conditions or financial model updates could lead to further adjustments in Chubb's valuation?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
